A study reported that during Spica Prunellae employed in TAO therapy, PI3K-AKT signaling pathway plays a central role in anti-TAO system (Zhang et al., 2020), suggesting the potential value of the PI3K-AKT signaling pathway in TAO treatment. Here, AKT1 is linked to thromboangiitis obliterans.